FR2381044B1 - - Google Patents

Info

Publication number
FR2381044B1
FR2381044B1 FR7804271A FR7804271A FR2381044B1 FR 2381044 B1 FR2381044 B1 FR 2381044B1 FR 7804271 A FR7804271 A FR 7804271A FR 7804271 A FR7804271 A FR 7804271A FR 2381044 B1 FR2381044 B1 FR 2381044B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7804271A
Other versions
FR2381044A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2381044A1 publication Critical patent/FR2381044A1/fr
Application granted granted Critical
Publication of FR2381044B1 publication Critical patent/FR2381044B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
FR7804271A 1977-02-17 1978-02-15 Procede pour la preparation de mefloquine Granted FR2381044A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76981677A 1977-02-17 1977-02-17

Publications (2)

Publication Number Publication Date
FR2381044A1 FR2381044A1 (fr) 1978-09-15
FR2381044B1 true FR2381044B1 (fr) 1983-06-10

Family

ID=25086585

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7804271A Granted FR2381044A1 (fr) 1977-02-17 1978-02-15 Procede pour la preparation de mefloquine

Country Status (9)

Country Link
JP (1) JPS53103478A (fr)
AT (1) AT358044B (fr)
BE (1) BE864002A (fr)
CH (2) CH640530A5 (fr)
DE (1) DE2806909A1 (fr)
FR (1) FR2381044A1 (fr)
GB (1) GB1594282A (fr)
IT (1) IT1158450B (fr)
NL (1) NL7801787A (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2940443A1 (de) * 1979-10-05 1981-04-16 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von erythro-(alpha)-2-piperidyl-2,8-bis-(trifluormethyl)-4-chinolin-methanol
FR2485014A1 (fr) * 1980-06-20 1981-12-24 Pharmindustrie Nouveaux derives de (quinolyl-2, -3 ou -4)-1 (piperidyl ou pyrrolidinyl-2 ou -3)-2 ou -3 ethanone ou propanone, procedes pour leur preparation, et leur utilisation comme medicaments
US4507482A (en) * 1982-04-14 1985-03-26 Hoffmann-La Roche Inc. Purification of mefloquin hydrochloride
DK160499C (da) * 1982-09-10 1991-08-26 Hoffmann La Roche Fremgangsmaade til fremstilling af mefloquin og mellemprodukt til anvendelse herved
JPH0234129U (fr) * 1989-05-25 1990-03-05
HUT54363A (en) * 1989-07-25 1991-02-28 Alkaloida Vegyeszeti Gyar Process for producing pyridyl-methyl-quinolin derivatives
GB9819382D0 (en) * 1998-09-04 1998-10-28 Cerebrus Ltd Chemical compounds I

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH590274A5 (fr) * 1970-03-16 1977-07-29 Hoffmann La Roche
CH605916A5 (fr) * 1973-12-07 1978-10-13 Hoffmann La Roche

Also Published As

Publication number Publication date
ATA113378A (de) 1980-01-15
CH640531A5 (en) 1984-01-13
NL7801787A (nl) 1978-08-21
CH640530A5 (en) 1984-01-13
IT1158450B (it) 1987-02-18
DE2806909A1 (de) 1978-08-24
IT7820331A0 (it) 1978-02-16
GB1594282A (en) 1981-07-30
FR2381044A1 (fr) 1978-09-15
JPS6257631B2 (fr) 1987-12-02
DE2806909C2 (fr) 1988-04-07
JPS53103478A (en) 1978-09-08
AT358044B (de) 1980-08-11
BE864002A (fr) 1978-08-16

Similar Documents

Publication Publication Date Title
CH656774GA3 (fr)
FR2376746B1 (fr)
DE2811260C3 (fr)
FR2376996B1 (fr)
FR2376829B1 (fr)
FR2378764B1 (fr)
FR2377695B1 (fr)
FR2377510B3 (fr)
AU3353778A (fr)
FR2377084B1 (fr)
FR2377161B1 (fr)
FR2377484B1 (fr)
FR2377681B1 (fr)
FR2377534B1 (fr)
FR2377822B1 (fr)
FR2378032B1 (fr)
DK141790C (fr)
DK141692C (fr)
AR210643A1 (fr)
AU495917B2 (fr)
AU71461S (fr)
BG26836A1 (fr)
BG25855A1 (fr)
BG25823A1 (fr)
BG25840A1 (fr)

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse